You can buy or sell TNDM and other stocks, options, ETFs, and crypto commission-free!
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. Read More The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Yahoo FinanceMar 14
Tandem Diabetes (TNDM) Hits a 52-Week High on Solid Prospects
Share price of Tandem Diabetes Care, Inc. TNDM scaled a new 52-week high of $74.37 on Mar 13, closing nominally lower at $71.42. Over the past six months, the company has gained 39.6%. The stock has a market cap of $4.12 billion. Further, Tandem’s estimate revision trend for the current quarter is favorable. In the past 30 days, two estimates have moved up while none shifted down. Consequently, estimates were up from a loss of 35 cents per share to a loss of 28 cents. The company’s five-year histor...
Simply Wall StMar 12
Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) A Financially Strong Company?
Stocks with market capitalization between $2B and $10B, such as Tandem Diabetes Care, Inc. (NASDAQ:TNDM) with a size of US$3.8b, do not attract as much attention from the investing community as do the small-caps and large-caps. While they are less talked about as an investment category, mid-cap risk-adjusted returns have generally been better than more commonly focused stocks that fall into the small- or large-cap categories. Today we will look at TNDM’s financial liquidity and debt levels, which are strong...
Yahoo FinanceMar 11
Tandem Diabetes Signs as an Insulin Pump Vendor in Canada
In line with Tandem Diabetes Care, Inc.'s TNDM focus on strengthening its global presence, the company recently announced thatit has been registered as an approved vendor of insulin pumps and supplies under the Assistive Devices Program (ADP) in Ontario, Canada. This development came close on the heels of the company receiving a Heath Canada Medical Device License for its t:slim X2 Insulin Pump. This t:slim X2 Insulin Pump features Dexcom G5 Mobile continuous glucose monitoring (CGM) integration. This in t...
Expected Apr 25, After Hours